Literature DB >> 6175381

Application of L-glutamic acid and substance P to the substantia nigra modulates in vivo [3H]serotonin release in the basal ganglia of the cat.

T Reisine, P Soubrie, F Artaud, J Glowinski.   

Abstract

L-Glutamic acid or substance P were applied to the caudate nucleus (CN) or substantia nigra (SN) and their effects on local, spontaneous, in vivo [3H]serotonin ([3H]5-HT) release as well as [3H]5-HT release in the contralateral CN and SN were studied using cats implanted with push-pull cannulae. L-Glutamic acid (5 x 10(-5) M), when applied to the CN or SN inhibited the local release of [3H]5-HT but did not affect release in the contralateral CN and SN. In the SN, the L-glutamic acid effect was blocked by L-glutamic acid diethylester. Substance P (10(-7) M) applied to the SN induced an increase in [3H]5-HT release that was delayed in onset. Furthermore, [3H]5-HT release was elevated in the contralateral CN immediately upon the application of substance P to the SN. These results suggest that L-glutamic acid and substance P may control 5-HT transmission in the basal ganglia.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6175381     DOI: 10.1016/0006-8993(82)90717-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

1.  The NK-3 tachykinin receptor agonist senktide elicits 5-HT-mediated behaviour following central or peripheral administration in mice and rats.

Authors:  A J Stoessl; C T Dourish; S D Iversen
Journal:  Br J Pharmacol       Date:  1988-06       Impact factor: 8.739

2.  Effects of thalamic lesion on the bilateral regulation of serotoninergic transmission in rat basal ganglia.

Authors:  D Becquet; M Faudon; F Hery
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

3.  Measurement of substance P and met-enkephalin in the serum of violent death victims.

Authors:  Lawrence Quarino; Robert C Shaler
Journal:  Forensic Sci Med Pathol       Date:  2006-12       Impact factor: 2.007

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.